Ait Abdellah, Samira http://orcid.org/0000-0001-8649-4598
Raverot, Véronique http://orcid.org/0000-0003-4336-1271
Gal, Caroline http://orcid.org/0000-0002-9157-2201
Guinobert, Isabelle
Bardot, Valérie
Blondeau, Claude http://orcid.org/0000-0002-0833-4633
Claustrat, Bruno
Clinical trials referenced in this document:
Documents that mention this clinical trial
Bioavailability of Melatonin after Administration of an Oral Prolonged-Release Tablet and an Immediate-Release Sublingual Spray in Healthy Male Volunteers
https://doi.org/10.1007/s40268-023-00431-9
Article History
Accepted: 22 June 2023
First Online: 12 July 2023
Declarations
:
: The study was funded by PiLeJe Laboratoire.
: S. Ait Abdellah, C. Gal, I. Guinobert, V. Bardot, and C. Blondeau are employees of PiLeJe Laboratoire. B. Claustrat has been a consultant for PiLeJe, Biocodex, and Sanofi. V. Raverot declared that she has no conflicts of interest.
: The study received a favorable opinion from a Personal Protection Committee (CPP Sud-Est I, CHU Saint Etienne, France) before its implementation on 10 July 2020.
: Data that support the findings of the study may be requested from the corresponding author.
: Not applicable.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Conceptualization: SAA, IG, BC; Methodology: SAA, IG, VB, CG, VR, BC; Formal analysis and investigation: SAA, IG, VB, CG, VR, BC; Writing—original draft preparation: CB; Writing—review and editing: CB, SAA, IG, VB, CG, VR, BC; Resources: CG, SAA; Supervision: CG, SAA. All authors read and approved the final manuscript.